Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity

被引：0
|
作者：
Kinga Sałat
机构：
[1] Jagiellonian University Medical College,Department of Pharmacodynamics
来源：
Pharmacological Reports | 2020年 / 72卷
关键词：
Oxaliplatin; Oxalate; Prevention strategies for CIPN; Duloxetine; Calmangafodipir; Clinical trials;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：508 / 527
页数：19
相关论文
共 50 条
  • [21] Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats
    Nishida, Kentaro
    Takeuchi, Kazuya
    Hosoda, Ayami
    Sugano, Shohei
    Morisaki, Eri
    Ohishi, Akihiro
    Nagasawa, Kazuki
    LIFE SCIENCES, 2018, 207 : 516 - 524
  • [22] Subjective and objective assessment of oxaliplatin-induced peripheral neuropathy
    Yoshida, Yoichiro
    Mogi, Ai
    Yamada, Teppei
    Aisu, Naoya
    Matsuoka, Taisuke
    Kojima, Daibo
    Tanimura, Syu
    Koganemaru, Tomoko
    Oda, Mayumi
    Fukuda, Mahiru
    Kiyomi, Fumiaki
    Noda, Keita
    Hirata, Keiji
    Yamashita, Yuichi
    SPRINGERPLUS, 2015, 4 : 1 - 5
  • [23] Nanoliposomal oxaliplatin ameliorates chemotherapy-induced neuropathy
    Alaei, Maryam
    Moetamani-Ahmadi, Mehrdad
    Mahaki, Hanie
    Fiuji, Hamid
    Maftooh, Mina
    Hassanian, Seyed Mahdi
    Khazaei, Majid
    Shahri, Ali Pourbagher
    Ferns, Gordon A.
    Frozanfar, Fatemeh
    Tanzadehpanah, Hamid
    Avan, Amir
    NEUROSCIENCE LETTERS, 2023, 812
  • [24] Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings
    Ibrahim, Eiman Y.
    Ehrlich, Barbara E.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [25] Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy
    Mezzanotte, Jessica N.
    Grimm, Michael
    Shinde, Namrata, V
    Nolan, Timiya
    Worthen-Chaudhari, Lise
    Williams, Nicole O.
    Lustberg, Maryam B.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (01) : 29 - 42
  • [26] Chemotherapy-induced peripheral neuropathy and neuropathic pain
    Schuler, U.
    Heller, S.
    SCHMERZ, 2017, 31 (04): : 413 - 425
  • [27] Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study
    Yokoyama, Satoshi
    Nakagawa, Chihiro
    Hosomi, Kouichi
    SUPPORTIVE CARE IN CANCER, 2022, 30 (02) : 1765 - 1773
  • [28] Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601
    Smith, E. M. L.
    Pang, H.
    Ye, C.
    Cirrincione, C.
    Fleishman, S.
    Paskett, E. D.
    Ahles, T.
    Bressler, L. R.
    Le-Lindqwister, N.
    Fadul, C. E.
    Loprinzi, C.
    Shapiro, C. L.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (02)
  • [29] Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial
    Salehi, Zeinab
    Roayaei, Mahnaz
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2015, 6
  • [30] Treatment strategy of oxaliplatin-induced peripheral neuropathy: a retrospective, nationwide study
    Satoshi Yokoyama
    Chihiro Nakagawa
    Kouichi Hosomi
    Supportive Care in Cancer, 2022, 30 : 1765 - 1773
12345